We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genetics Companies End Patent Dispute Over HPV Test

Law360 (January 13, 2006, 12:00 AM EST) -- Two feuding genetic testing product companies have ended a patent dispute over testing methods used to detect risk for the human papilloma virus, a common sexually transmitted infection that causes cervical cancer.

The settlement agreement comes about three months after Third Wave Technologies Inc. sued the Maryland-based Digene Corporation, seeking declaratory judgment supporting Third Wave's right to sell its HPV products.

In a press release on Friday, Digene stated that Third Wave had dismissed the suit without prejudice. Representatives from both companies could not be reached...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.